63 related articles for article (PubMed ID: 38688627)
1. Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
Yang JD; Liu YC; Wang HC; Hsu FT; Liao TL; Huang MC; Chen JH
In Vivo; 2024; 38(3):1079-1093. PubMed ID: 38688627
[TBL] [Abstract][Full Text] [Related]
2. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo.
Su CM; Lin SS; Wang HC; Hsu FT; Chung JG; Hsu LC
Environ Toxicol; 2022 Jan; 37(1):92-100. PubMed ID: 34626444
[TBL] [Abstract][Full Text] [Related]
4. ERK/AKT Inactivation and Apoptosis Induction Associate With Quetiapine-inhibited Cell Survival and Invasion in Hepatocellular Carcinoma Cells.
Lee YJ; Chung JG; Tan ZL; Hsu FT; Liu YC; Lin SS
In Vivo; 2020; 34(5):2407-2417. PubMed ID: 32871766
[TBL] [Abstract][Full Text] [Related]
5. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
6. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
7. Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid.
Yang JD; Yueh PF; Liao TL; Chen YT; Hsu FT; Chiang IT; Chang CM; Wang WS
Anticancer Res; 2023 Oct; 43(10):4403-4412. PubMed ID: 37772586
[TBL] [Abstract][Full Text] [Related]
8. Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer.
Li T; Liu X; Long X; Li Y; Xiang J; Lv Y; Zhao X; Shi S; Chen W
Environ Toxicol; 2023 Oct; 38(10):2352-2360. PubMed ID: 37347510
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of EGFR/ERK/NF-κB signalling associates with radiosensitizing effect of 18β-glycyrrhetinic acid on progression of hepatocellular carcinoma.
Liu YC; Lin CH; Chen KT; Lai DW; Hsu FT
J Cell Mol Med; 2023 Jun; 27(11):1539-1549. PubMed ID: 37177859
[TBL] [Abstract][Full Text] [Related]
10. The impact of schizophrenia spectrum disorder, bipolar disorder and borderline personality disorder on radiotherapy treatment and overall survival in cancer patients: A matched pair analysis.
Peters M; Boersma HW; van Rossum PSN; van Oort J; Cahn W; Verhoeff JJC
Clin Transl Radiat Oncol; 2023 May; 40():100618. PubMed ID: 37066114
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone induces caspase-dependent/-independent apoptosis and dysregulates cyclin-dependent kinase-mediated cell cycle in colorectal cancer in vitro and in vivo.
Lin CH; Lin KH; Ku HJ; Lee KC; Lin SS; Hsu FT
Environ Toxicol; 2023 May; 38(5):1078-1089. PubMed ID: 36727907
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence.
Gao Z; Xi Y; Shi H; Ni J; Xu W; Zhang K
Front Oncol; 2022; 12():993367. PubMed ID: 36591471
[TBL] [Abstract][Full Text] [Related]
13. COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells.
Park J; Jeong JY; Kang SS
Anticancer Res; 2022 Dec; 42(12):5773-5781. PubMed ID: 36456159
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
